Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1-10 brain metastases treated with stereotactic radiosurgery.

CONCLUSION: DS-GPA seems to be a reliable tool to classify patients with brain metastases treated with SRS into prognostic subgroups. However, we found some aberrations from predicted median survival times, which may be due to specific characteristics of the populations of patients treated with SRS versus other patients. PMID: 31302392 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31302392?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - July 10, 2019 Category: Radiology Authors: Nagtegaal S, Claes A, Suijkerbuijk K, Schramel F, Snijders T, Verhoeff J Tags: Radiother Oncol Source Type: research